Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anterix (ATEX) Capital Expenditures (2016 - 2025)

Anterix's Capital Expenditures history spans 12 years, with the latest figure at $9000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures changed N/A year-over-year to $9000.0; the TTM value through Dec 2025 reached $96000.0, up 18.52%, while the annual FY2025 figure was $87000.0, 71.66% down from the prior year.
  • Capital Expenditures reached $9000.0 in Q4 2025 per ATEX's latest filing, down from $46000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.1 million in Q3 2022 to a low of -$4000.0 in Q1 2021.
  • Average Capital Expenditures over 5 years is $223625.0, with a median of $49500.0 recorded in 2021.
  • Peak YoY movement for Capital Expenditures: tumbled 107.84% in 2021, then skyrocketed 20125.0% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $43000.0 in 2021, then skyrocketed by 825.58% to $398000.0 in 2022, then plummeted by 86.18% to $55000.0 in 2023, then dropped by 25.45% to $41000.0 in 2024, then crashed by 78.05% to $9000.0 in 2025.
  • Per Business Quant, the three most recent readings for ATEX's Capital Expenditures are $9000.0 (Q4 2025), $46000.0 (Q1 2025), and $41000.0 (Q3 2024).